O'Grady A - Search Results

1

External quality assurance of HER2 FISH and ISH testing: three years of the UK national external quality assurance scheme.

Bartlett JM, Ibrahim M, Jasani B, Morgan JM, Ellis I, Kay E, Connolly Y, Campbell F, O'Grady A, Barnett S, Miller K. Bartlett JM, et al. Am J Clin Pathol. 2009 Jan;131(1):106-11. doi: 10.1309/AJCPLN78ZQXEMNMA. Am J Clin Pathol. 2009. PMID: 19095573

2

Chromogenic in situ hybridization: a multicenter study comparing silver in situ hybridization with FISH.

Bartlett JM, Campbell FM, Ibrahim M, Wencyk P, Ellis I, Kay E, Connolly Y, O'Grady A, Di Palma S, Starczynski J, Morgan JM, Jasani B, Miller K. Bartlett JM, et al. Am J Clin Pathol. 2009 Oct;132(4):514-20. doi: 10.1309/AJCPXY3MJ6GSRCYP. Am J Clin Pathol. 2009. PMID: 19762528

3

A UK NEQAS ICC and ISH multicentre study using the Kreatech Poseidon HER2 FISH probe: intersite variation can be rigorously controlled using FISH.

Bartlett JM, Campbell FM, Ibrahim M, Thomas J, Wencyk P, Ellis I, Kay E, Connolly Y, O'Grady A, Barnett S, Starczynski J, Cunningham P, Miller K. Bartlett JM, et al. Histopathology. 2010 Feb;56(3):297-304. doi: 10.1111/j.1365-2559.2010.03493.x. Histopathology. 2010. PMID: 20459530

4

A UK NEQAS ISH multicenter ring study using the Ventana HER2 dual-color ISH assay.

Bartlett JM, Campbell FM, Ibrahim M, O'Grady A, Kay E, Faulkes C, Collins N, Starczynski J, Morgan JM, Jasani B, Miller K. Bartlett JM, et al. Am J Clin Pathol. 2011 Jan;135(1):157-62. doi: 10.1309/AJCPVPRKK1ENEDGQ. Am J Clin Pathol. 2011. PMID: 21173138

5

Use of tissue microarray for interlaboratory validation of HER2 immunocytochemical and FISH testing.

Kay E, O'Grady A, Morgan JM, Wozniak S, Jasani B. Kay E, et al. J Clin Pathol. 2004 Nov;57(11):1140-4. doi: 10.1136/jcp.2003.014910. J Clin Pathol. 2004. PMID: 15509672 Free PMC article.

6

HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods.

Bartlett JM, Starczynski J, Atkey N, Kay E, O'Grady A, Gandy M, Ibrahim M, Jasani B, Ellis IO, Pinder SE, Walker RA. Bartlett JM, et al. J Clin Pathol. 2011 Aug;64(8):649-53. doi: 10.1136/jcp.2011.089847. Epub 2011 Jun 20. J Clin Pathol. 2011. PMID: 21690244

7

Miniature tissue microarrays for HercepTest standardisation and analysis.

Gulmann C, Loring P, O'Grady A, Kay E. Gulmann C, et al. J Clin Pathol. 2004 Nov;57(11):1229-31. doi: 10.1136/jcp.2004.018689. J Clin Pathol. 2004. PMID: 15509692 Free PMC article.

8

HER-2 analysis in tissue microarrays of archival human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization.

O'Grady A, Flahavan CM, Kay EW, Barrett HL, Leader MB. O'Grady A, et al. Appl Immunohistochem Mol Morphol. 2003 Jun;11(2):177-82. doi: 10.1097/00129039-200306000-00016. Appl Immunohistochem Mol Morphol. 2003. PMID: 12778005

9

HER2 positivity in breast carcinoma: a comparison of chromogenic in situ hybridization with fluorescence in situ hybridization in tissue microarrays, with targeted evaluation of intratumoral heterogeneity by in situ hybridization.

Loring P, Cummins R, O'Grady A, Kay EW. Loring P, et al. Appl Immunohistochem Mol Morphol. 2005 Jun;13(2):194-200. doi: 10.1097/01.pai.0000132189.01233.6d. Appl Immunohistochem Mol Morphol. 2005. PMID: 15894935

10

Tissue microarray technology in the routine assessment of HER2 status in invasive breast cancer.

Cryan J, O'Grady A, Allen D, Kay E. Cryan J, et al. Histopathology. 2009 Jun;54(7):901. doi: 10.1111/j.1365-2559.2009.03304.x. Histopathology. 2009. PMID: 19635107 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters